NCT00881231View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Pain
Interventions
DRUG

Cilostazol 50 mg Tablets (Eon Pharma, LLC, USA)

DRUG

Pletal (Cilostazol) 50 mg Tablets (Otsuka Pharma Co, Ltd., USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY